Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
October 2012 Volume 30 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October 2012 Volume 30 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Downregulation of nucleoporin 88 and 214 induced by oridonin may protect OCIM2 acute erythroleukemia cells from apoptosis through regulation of nucleocytoplasmic transport of NF-κB

  • Authors:
    • Sha Yi
    • Yan Chen
    • Lu Wen
    • Lijing Yang
    • Guohui Cui
  • View Affiliations / Copyright

    Affiliations: Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P.R. China
  • Pages: 877-883
    |
    Published online on: July 18, 2012
       https://doi.org/10.3892/ijmm.2012.1067
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Oridonin has been utilized for the treatment of various human diseases due to its anti-inflammatory, antibacterial and antitumor effects. However, the precise mechanisms induced by oridonin in human erythroleukemia are yet to be clarified. The present study aimed to elucidate possible oridonin‑induced apoptotic mechanisms in OCIM2 cells, as well as the possible mechanisms whereby OCIM2 cells are relatively resistant to oridonin. Results in the present study showed that oridonin significantly inhibited OCIM2 and OCI-AML3 cell proliferation in a dose- and time-dependent manner, while expressing a much higher IC50 in OCIM2, compared to OCI-AML3. These results also indicated that oridonin induced OCIM2 cell apoptosis, associated with p65 and Bax, while activating caspases-9, -6 and -3. However, p65 was only partly translocated into the nucleus, while most of the p65 was retained in the cytoplasm. Moreover, nucleoporin 214 (Nup214) and nucleoporin 88 (Nup88) were downregulated at the transcriptional and protein levels, subsequent to oridonin treatment. Taken together, these data suggest that oridonin has the potential to induce OCIM2 cell-apoptosis, involving NF-κB activation, whereas the downregulation of Nup88 and Nup214 may protect OCIM2 through the regulation of the nucleocytoplasmic transport of p65.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1. 

FP SantosCE Bueso-RamosF RavandiAcute erythroleukemia: diagnosis and managementExpert Rev Hematol3705718201010.1586/ehm.10.6221091147

2. 

MS HaydenS GhoshShared principles in NF-kappaB signalingCell132344362200810.1016/j.cell.2008.01.02018267068

3. 

KM RyanMK ErnstNR RiceKH VousdenRole of NF-kappaB in p53-mediated programmed cell deathNature404892897200010.1038/3500913010786798

4. 

V BaudM KarinIs NF-kappaB a good target for cancer therapy?Hopes and pitfalls Nat Rev Drug Discov83340200910.1038/nrd278119116625

5. 

ND PerkinsTD GilmoreGood cop, bad cop: the different faces of NF-kappaBCell Death Differ13759772200610.1038/sj.cdd.440183816410803

6. 

K WeisNucleocytoplasmic transport: cargo trafficking across the borderCurr Opin Cell Biol14328335200210.1016/S0955-0674(02)00337-X12067655

7. 

VE GouldA OrucevicH ZentgrafP GattusoN MartinezA AlonsoNup88 (karyoporin) in human malignant neoplasms and dysplasias: correlations of immunostaining of tissue sections, cytologic smears, and immunoblot analysisHum Pathol33536544200210.1053/hupa.2002.124785

8. 

VE GouldN MartinezA OrucevicJ SchneiderA AlonsoA novel, nuclear pore-associated, widely distributed molecule overexpressed in oncogenesis and developmentAm J Pathol15716051613200010.1016/S0002-9440(10)64798-011073820

9. 

A EmterlingJ SkoglundG ArbmanClinicopathological significance of Nup88 expression in patients with colorectal cancerOncology64361369200310.1159/00007029412759533

10. 

M FornerodM OhnoM YoshidaIW MattajCRM1 is an export receptor for leucine-rich nuclear export signalsCell9010511060199710.1016/S0092-8674(00)80371-29323133

11. 

F GaoQ TangP YangY FangW LiY WuApoptosis inducing and differentiation enhancement effect of oridonin on the all-trans-retinoic acid-sensitive and -resistant acute promyelocytic leukemia cellsInt J Lab Hematol32e114e122201010.1111/j.1751-553X.2009.01147.x

12. 

GB ZhouSJ ChenZY WangZ ChenBack to the future of oridonin: again, compound from medicinal herb shows potent antileukemia efficacies in vitro and in vivoCell Res17274276200710.1038/cr.2007.2117426700

13. 

FH GaoF LiuW WeiOridonin induces apoptosis and senescence by increasing hydrogen peroxide and glutathione depletion in colorectal cancer cellsInt J Mol Med29649655201222294162

14. 

Z JiQJ TangJS ZhangY YangYF LiuYJ PanOridonin-induced apoptosis in SW620 human colorectal adenocarcinoma cellsOncol Lett213031307201122848306

15. 

S GhoshM KarinMissing pieces in the NF-kappaB puzzleCell109SupplS81S96200210.1016/S0092-8674(02)00703-111983155

16. 

V KirkinS JoosM ZornigThe role of Bcl-2 family members in tumorigenesisBiochim Biophys Acta1644229249200410.1016/j.bbamcr.2003.08.00914996506

17. 

NA ThornberryCaspases: key mediators of apoptosisChem Biol5R97R103199810.1016/S1074-5521(98)90615-99578633

18. 

R BernadD EngelsmaH SandersonH PickersgillM FornerodNup214-Nup88 nucleoporin subcomplex is required for CRM1-mediated 60 S preribosomal nuclear exportJ Biol Chem2811937819386200610.1074/jbc.M51258520016675447

19. 

S HuttenRH KehlenbachNup214 is required for CRM1-dependent nuclear protein export in vivoMol Cell Biol2667726785200610.1128/MCB.00342-0616943420

20. 

AE UvP RothN XylourgidisA WickbergR CanteraC Samakovlismembers only encodes a Drosophila nucleoporin required for rel protein import and immune response activationGenes Dev1419451957200010921908

21. 

P RothN XylourgidisN SabriA UvM FornerodC SamakovlisThe Drosophila nucleoporin DNup88 localizes DNup214 and CRM1 on the nuclear envelope and attenuates NES-mediated nuclear exportJ Cell Biol1637017062003

22. 

N XylourgidisP RothN SabriV TsarouhasC SamakovlisThe nucleoporin Nup214 sequesters CRM1 at the nuclear rim and modulates NFkappaB activation in DrosophilaJ Cell Sci11944094419200610.1242/jcs.0320117032737

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yi S, Chen Y, Wen L, Yang L and Cui G: Downregulation of nucleoporin 88 and 214 induced by oridonin may protect OCIM2 acute erythroleukemia cells from apoptosis through regulation of nucleocytoplasmic transport of NF-κB. Int J Mol Med 30: 877-883, 2012.
APA
Yi, S., Chen, Y., Wen, L., Yang, L., & Cui, G. (2012). Downregulation of nucleoporin 88 and 214 induced by oridonin may protect OCIM2 acute erythroleukemia cells from apoptosis through regulation of nucleocytoplasmic transport of NF-κB. International Journal of Molecular Medicine, 30, 877-883. https://doi.org/10.3892/ijmm.2012.1067
MLA
Yi, S., Chen, Y., Wen, L., Yang, L., Cui, G."Downregulation of nucleoporin 88 and 214 induced by oridonin may protect OCIM2 acute erythroleukemia cells from apoptosis through regulation of nucleocytoplasmic transport of NF-κB". International Journal of Molecular Medicine 30.4 (2012): 877-883.
Chicago
Yi, S., Chen, Y., Wen, L., Yang, L., Cui, G."Downregulation of nucleoporin 88 and 214 induced by oridonin may protect OCIM2 acute erythroleukemia cells from apoptosis through regulation of nucleocytoplasmic transport of NF-κB". International Journal of Molecular Medicine 30, no. 4 (2012): 877-883. https://doi.org/10.3892/ijmm.2012.1067
Copy and paste a formatted citation
x
Spandidos Publications style
Yi S, Chen Y, Wen L, Yang L and Cui G: Downregulation of nucleoporin 88 and 214 induced by oridonin may protect OCIM2 acute erythroleukemia cells from apoptosis through regulation of nucleocytoplasmic transport of NF-κB. Int J Mol Med 30: 877-883, 2012.
APA
Yi, S., Chen, Y., Wen, L., Yang, L., & Cui, G. (2012). Downregulation of nucleoporin 88 and 214 induced by oridonin may protect OCIM2 acute erythroleukemia cells from apoptosis through regulation of nucleocytoplasmic transport of NF-κB. International Journal of Molecular Medicine, 30, 877-883. https://doi.org/10.3892/ijmm.2012.1067
MLA
Yi, S., Chen, Y., Wen, L., Yang, L., Cui, G."Downregulation of nucleoporin 88 and 214 induced by oridonin may protect OCIM2 acute erythroleukemia cells from apoptosis through regulation of nucleocytoplasmic transport of NF-κB". International Journal of Molecular Medicine 30.4 (2012): 877-883.
Chicago
Yi, S., Chen, Y., Wen, L., Yang, L., Cui, G."Downregulation of nucleoporin 88 and 214 induced by oridonin may protect OCIM2 acute erythroleukemia cells from apoptosis through regulation of nucleocytoplasmic transport of NF-κB". International Journal of Molecular Medicine 30, no. 4 (2012): 877-883. https://doi.org/10.3892/ijmm.2012.1067
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team